Modulation of Osteoclast Interactions with Orthopaedic Biomaterials
Source abstract
Abstract
Biomaterial integration in bone depends on bone remodelling at the bone-implant interface. Optimal balance of bone resorption by osteoclasts and bone deposition by osteoblasts is crucial for successful implantation, especially in orthopaedic surgery. Most studies examined osteoblast differentiation on biomaterials, yet few research has been conducted to explore the effect of different orthopaedic implants on osteoclast development. This review covers, in detail, the biology of osteoclasts, in vitro models of osteoclasts, and modulation of osteoclast activity by different implant surfaces, bio-ceramics, and polymers. Studies show that surface topography influence osteoclastogenesis. For instance, metal implants with rough surfaces enhanced osteoclast activity, while smooth surfaces resulted in poor osteoclast differentiation. In addition, surface modification of implants with anti-osteoporotic drug further decreased osteoclast activity. In bioceramics, osteoclast development depended on different chemical compositions. Strontium-incorporated bioceramics decreased osteoclast development, whereas higher concentrations of silica enhanced osteoclast activity. Differences between natural and synthetic polymers also modulated osteoclastogenesis. Physiochemical properties of implants affect osteoclast activity. Hence, understanding osteoclast biology and its response to the natural microarchitecture of bone are indispensable to design suitable implant interfaces and scaffolds, which will stimulate osteoclasts in ways similar to that of native bone.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Bone Metabolism and Diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Orthopaedic Surgery, Yong Loo Lin School of Medicine, National University of Singapore, NUHS Tower Block, Level 11, 1E Kent Ridge Road, Singapore 119228, Singapore
References (96)
Show source-provided references
1. Bone remodelling: Should we cry wolff?10.1007/BF02946474 ↗
2. Mechanism of bone turnover10.3109/07853899309147297 ↗
3. Bone bonding at natural and biomaterial surfaces10.1016/j.biomaterials.2007.07.049 ↗
4. Osteoclast differentiation and activation10.1038/nature01658 ↗
5. The osteoblast: A sophisticated fibroblast under central surveillance10.1126/science.289.5484.1501 ↗
6. Bone resorption by osteoclasts10.1126/science.289.5484.1504 ↗
7. The role of osteoclasts in bone tissue engineering10.1002/term.1851 ↗
8. Osteoimmunology and the effects of the immune system on bone10.1038/nrrheum.2009.217 ↗
9. Cellular and molecular mechanisms of bone remodeling10.1074/jbc.R109.041087 ↗
10. The reversal phase of the bone-remodeling cycle: Cellular prerequisites for coupling resorption and formation10.1038/bonekey.2014.56 ↗
11. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures10.1007/s00198-006-0172-4 ↗
12. Local drug delivery for enhancing fracture healing in osteoporotic bone10.1016/j.actbio.2014.09.006 ↗
13. Distal femoral fractures: Current treatment, results and problems10.1016/S0020-1383(01)00179-6 ↗
14. Distal femoral fractures: Long-term outcome following stabilisation with the LISS10.1016/S0020-1383(03)00247-X ↗
15. The results of open reduction and internal fixation of distal femur fractures using a biologic (indirect) reduction technique10.1097/00005131-199608000-00002 ↗
16. Osteosynthesis systems in fragility fracture
17. Healing of subtrochanteric atypical fractures after strontium ranelate treatment
18. Anti-osteoporosis therapy and fracture healing10.1007/s00402-012-1558-8 ↗
19. An AOA critical issue. Geriatric trauma: Young ideas10.2106/00004623-200307000-00027 ↗
20. Stress shielding and fracture healing
21. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures10.2106/00004623-200212000-00001 ↗
22. Clinical applications of BMP-7: The UK perspective10.1016/j.injury.2005.07.035 ↗
23. Improving fixation of the osteoporotic fracture: The role of locked plating10.1097/BOT.0b013e31821b8a52 ↗
24. Implant Augmentation: Adding Bone Cement to Improve the Treatment of Osteoporotic Distal Femur Fractures: A Biomechanical Study Using Human Cadaver Bones10.1097/MD.0000000000000166 ↗
25. Simple coating with fibronectin fragment enhances stainless steel screw osseointegration in healthy and osteoporotic rats10.1016/j.biomaterials.2015.06.025 ↗
26. Dual modulation of bone formation and resorption with zoledronic acid-loaded biodegradable magnesium alloy implants improves osteoporotic fracture healing: An in vitro and in vivo study10.1016/j.actbio.2017.10.033 ↗
27. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function10.1006/bbrc.1999.0252 ↗
28. Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis10.1007/s007740070018 ↗
29. Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors10.1172/JCI116179 ↗
30. Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts10.1074/jbc.275.7.4858 ↗
31. Bacterial lipopolysaccharide induces osteoclast formation in RAW 264.7 macrophage cells10.1016/j.bbrc.2007.06.023 ↗
32. Cytoskeletal changes in osteoclasts during the resorption cycle10.1002/(SICI)1097-0029(19960201)33:2<171::AID-JEMT7>3.0.CO;2-W ↗
33. Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells
34. Osteoclastic bone resorption by a polarized vacuolar proton pump10.1126/science.2528207 ↗
35. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts10.1016/0014-4827(88)90191-7 ↗
36. Study of immunoelectron microscopic localization of cathepsin K in osteoclasts and other bone cells in the mouse femur10.1016/S8756-3282(98)00138-0 ↗
37. Proteolytic Activity of Human Osteoclast Cathepsin K: Expression, Purification, Activation, and Substrate Identification10.1074/jbc.271.21.12517 ↗
38. Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases10.1002/jcp.1041500202 ↗
39. Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function10.1007/BF02411252 ↗
40. Enhanced osteoclast-like cell functions on nanophase ceramics10.1016/S0142-9612(00)00285-4 ↗
41. The effects of inorganic additives to calcium phosphate on in vitro behavior of osteoblasts and osteoclasts10.1016/j.biomaterials.2010.01.002 ↗
42. Bioactive glass foam scaffolds are remodelled by osteoclasts and support the formation of mineralized matrix and vascular networks in vitro10.1002/adhm.201200140 ↗
43. A comparison of osteoclast resorption pits on bone with titanium and zirconia surfaces10.1016/j.biomaterials.2010.06.009 ↗
44. Cell lines and primary cell cultures in the study of bone cell biology10.1016/j.mce.2003.06.002 ↗
45. A simplified method for the generation of human osteoclasts in vitro
46. Isolated osteoclast cultures
47. RANKL-mediated osteoclast formation from murine RAW 264.7 cells10.1007/978-1-61779-415-5_13 ↗
48. Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts10.1006/bbrc.1997.8046 ↗
49. Biomaterial developments for bone tissue engineering10.1016/S0142-9612(00)00102-2 ↗
50. The use of fibrin glue in skin grafts and tissue-engineered skin replacements: A review10.1097/00006534-200111000-00045 ↗
51. Weaving for heart valve tissue engineering10.1016/j.biotechadv.2017.07.012 ↗
52. Role of the osteoclast at the bone-implant interface10.1177/08959374990130011401 ↗
53. Ti based biomaterials, the ultimate choice for orthopaedic implants—A review10.1016/j.pmatsci.2008.06.004 ↗
54. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 203010.2106/00004623-200704000-00012 ↗
55. The interface zone of inorganic implantsIn vivo: Titanium implants in bone10.1007/BF02363944 ↗
56. Biological surface science10.1016/S0039-6028(01)01809-X ↗
57. Wear particles and surface topographies are modulators of osteoclastogenesis in vitro10.1002/jbm.a.30202 ↗
58. Response of osteoclasts to titanium surfaces with increasing surface roughness: An in vitro study10.1007/s13758-012-0034-x ↗
59. The Dimension of Titania Nanotubes Influences Implant Success for Osteoclastogenesis and Osteogenesis Patients10.1166/jnn.2015.9602 ↗
60. Titanium surface roughness accelerates RANKL-dependent differentiation in the osteoclast precursor cell line, RAW264.710.4012/dmj.26.739 ↗
61. Effects of surface microtopography on the assembly of the osteoclast resorption apparatus10.1098/rsif.2011.0659 ↗
62. Implant surface roughness and bone healing: A systematic review10.1177/154405910608500603 ↗
63. Topography Influences Adherent Cell Regulation of Osteoclastogenesis10.1177/0022034515616760 ↗
64. Immobilized-OPG-Fc on a titanium surface inhibits RANKL-dependent osteoclast differentiation in vitro10.1007/s10856-009-3891-1 ↗
65. Local delivery of bisphosphonate from coated orthopedic implants increases implants mechanical stability in osteoporotic rats10.1002/jbm.a.30456 ↗
66. Enhancement of local bone remodeling in osteoporotic rabbits by biomimic multilayered structures on Ti6Al4V implants10.1002/jbm.a.35667 ↗
67. Hydroxyapatite nanocrystals functionalized with alendronate as bioactive components for bone implant coatings to decrease osteoclastic activity10.1016/j.apsusc.2014.12.072 ↗
68. Biomaterials in orthopaedics10.1098/rsif.2008.0151 ↗
69. Bioceramics: From Concept to Clinic10.1111/j.1151-2916.1991.tb07132.x ↗
70. Osteoclastic resorption of calcium phosphate ceramics with different hydroxyapatite/beta-tricalcium phosphate ratios10.1016/S0142-9612(97)00036-7 ↗
71. Influence of phase composition on degradation and resorption of biphasic calcium phosphate ceramics
72. Resorption of sintered synthetic hydroxyapatite by osteoclasts in vitro10.1016/0142-9612(93)90216-O ↗
73. Formation of osteoclast-like cells on HA and TCP ceramics10.1016/j.actbio.2007.03.014 ↗
74. The effects of strontium-substituted bioactive glasses on osteoblasts and osteoclasts in vitro10.1016/j.biomaterials.2010.01.121 ↗
75. Effects of Zinc and Strontium Substitution in Tricalcium Phosphate on Osteoclast Differentiation and Resorption10.1039/C2BM00012A ↗
76. Osteoclastogenesis and osteoclastic resorption of tricalcium phosphate: Effect of strontium and magnesium doping10.1002/jbm.a.34181 ↗
77. Inhibitory effect of Zn2+ in zinc-containing beta-tricalcium phosphate on resorbing activity of mature osteoclasts10.1002/jbm.a.31265 ↗
78. Strontium substitution in apatitic CaP cements effectively attenuates osteoclastic resorption but does not inhibit osteoclastogenesis10.1016/j.actbio.2016.04.016 ↗
79. In vitro osteoclast formation and resorption of silicon-substituted hydroxyapatite ceramics10.1002/jbm.a.35470 ↗
80. Osteoblast and osteoclast differentiation in an in vitro three-dimensional model of bone10.1089/ten.tea.2008.0501 ↗
81. Differentiation of mononuclear precursors into osteoclasts on the surface of Si-substituted hydroxyapatite10.1002/jbm.a.30726 ↗
82. Effects of Silicon on Osteoclast Cell Mediated Degradation, In Vivo Osteogenesis and Vasculogenesis of Brushite Cement10.1039/C5TB01081K ↗
83. Intact surface of bioactive glass S53P4 is resistant to osteoclastic activity10.1002/jbm.a.30600 ↗
84. Sol-gel bioactive glasses support both osteoblast and osteoclast formation from human bone marrow cells10.1002/jbm.a.31386 ↗
85. AP40 Bioactive Glass Ceramic by Sol-Gel Synthesis: In Vitro Dissolution and Cell-Mediated Bioresorption10.4028/www.scientific.net/KEM.541.41 ↗
86. Hydroxyapatite surface roughness: Complex modulation of the osteoclastogenesis of human precursor cells10.1016/j.actbio.2011.11.032 ↗
87. Osteoclast resorption of thermal spray hydoxyapatite coatings is influenced by surface topography10.1016/j.actbio.2012.01.023 ↗
88. The differential regulation of osteoblast and osteoclast activity by surface topography of hydroxyapatite coatings10.1016/j.biomaterials.2013.06.014 ↗
89. Osteoclast resorption of beta-tricalcium phosphate controlled by surface architecture10.1016/j.biomaterials.2014.05.048 ↗
90. Fibrinogen promotes resorption of chitosan by human osteoclasts10.1016/j.actbio.2013.01.015 ↗
91. In vitro osteoclastogenesis on textile chitosan scaffold10.22203/eCM.v019a10 ↗
92. Differentiation and activity of human preosteoclasts on chitosan enriched calcium phosphate cement10.1016/j.biomaterials.2009.04.044 ↗
93. Monocyte proliferation and differentiation to osteoclasts is affected by density of collagen covalently bound to a poly(dimethyl siloxane) culture surface10.1002/jbm.a.34097 ↗
94. Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) composite biomaterials for bone tissue regeneration: In vitro performance assessed by osteoblast proliferation, osteoclast adhesion and resorption, and macrophage proinflammatory response10.1002/jbm.a.31174 ↗
95. Osteoblast: Osteoclast co-cultures on silk fibroin, chitosan and PLLA films10.1016/j.biomaterials.2009.07.028 ↗
96. Human iPSC-derived osteoblasts and osteoclasts together promote bone regeneration in 3D biomaterials10.1038/srep26761 ↗